The number of people living with a history of cancer in the United States continues to rise because of the growth and aging of the population as well as improved survival through advances in early detection and treatment. To assist the public health community serve the needs of these survivors, the American Cancer Society and the National Cancer Institute collaborate triennially to estimate cancer prevalence in the United States using data from the Surveillance, Epidemiology, and End Results cancer registries, the Centers for Disease Control and Prevention's National Center for Health Statistics, and the United States Census Bureau. In addition, cancer treatment patterns are presented from the National Cancer Database along with a brief overview of treatment-related side effects. As of January 1, 2025, about 18.6 million people were living in the United States with a history of cancer, and this number is projected to exceed 22 million by 2035. The three most prevalent cancers are prostate (3,552,460), melanoma of the skin (816,580), and colorectum (729,550) among males and breast (4,305,570), uterine corpus (945,540), and thyroid (859,890) among females. About one half (51%) of survivors were diagnosed within the past 10 years, and nearly four fifths (79%) were aged 60 years and older. Racial differences in treatment in 2021 were common across disease stage; for example, Black people with stage I-II lung cancer were less likely to undergo surgery than their White counterparts (47% vs. 52%). Larger disparities exist for rectal cancer, for which 39% of Black people with stage I disease undergo proctectomy or proctocolectomy compared to 64% of their White counterparts. Targeted, multi-level efforts to expand access to high-quality care and survivorship resources are vital to reducing disparities and advancing support for all survivors of cancer.

中文翻译：

---

2025 年癌症治疗和存活率统计

由于人口的增长和老龄化以及通过早期检测和治疗的进步提高生存率，美国有癌症病史的人数继续增加。为了帮助公共卫生界满足这些幸存者的需求，美国癌症协会和美国国家癌症研究所每三年合作一次，使用来自癌症监测、流行病学和最终结果登记处、疾病控制和预防中心的国家卫生统计中心和美国人口普查局的数据来估计美国的癌症患病率。此外，美国国家癌症数据库中还介绍了癌症治疗模式以及治疗相关副作用的简要概述。截至 2025 年 1 月 1 日，美国约有 1860 万人有癌症病史，预计到 2035 年这一数字将超过 2200 万。三种最常见的癌症是前列腺癌 （3,552,460）、男性皮肤黑色素瘤 （816,580） 和结直肠癌 （729,550），女性乳腺癌 （4,305,570）、子宫体 （945,540） 和甲状腺 （859,890）。大约一半 （51%） 的幸存者是在过去 10 年内被诊断出来的，近五分之四 （79%） 的年龄在 60 岁及以上。2021 年治疗的种族差异在各个疾病阶段都很常见;例如，患有 I-II 期肺癌的黑人比白人接受手术的可能性更小（47% 对 52%）。直肠癌存在更大的差异，39% 的 I 期黑人患者接受了直肠切除术或直肠结肠切除术，而白人为 64%。 有针对性地开展多层次努力，扩大获得高质量护理和幸存者资源的机会，对于缩小差距和推进对所有癌症幸存者的支持至关重要。